4-Chloro-6-(4-chlorophenyl)-2-(pyridin-4-yl)pyrimidine-5-carbonitrile

Catalog No. :
ACLNAH826
CAS No. :
320417-67-2
Molecular Formula :
C16H8Cl2N4
Molecular Weight :
327.17

IUPAC Name:4-chloro-6-(4-chlorophenyl)-2-(pyridin-4-yl)pyrimidine-5-carbonitrile

4-Chloro-6-(4-chlorophenyl)-2-(pyridin-4-yl)pyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-6-(4-chlorophenyl)-2-(pyridin-4-yl)pyrimidine-5-carbonitrile
IUPAC Name4-chloro-6-(4-chlorophenyl)-2-(pyridin-4-yl)pyrimidine-5-carbonitrile
MDL No.MFCD00139453
Molecular FormulaC16H8Cl2N4
Molecular Weight327.17
SMILESN#CC1=C(C2=CC=C(Cl)C=C2)N=C(C3=CC=NC=C3)N=C1Cl
InChI KeyQRWIMUFMRSENIA-UHFFFAOYSA-N
Synonym4-CHLORO-6-(4-CHLOROPHENYL)-2-(4-PYRIDINYL)-5-PYRIMIDINECARBONITRILE;5-Pyrimidinecarbonitrile, 4-chloro-6-(4-chlorophenyl)-2-(4-pyridinyl)-;4-Chloro-6-(4-chlorophenyl)-2-(4-pyridyl)pyrimidine-5-carbonitrile
CAS No.320417-67-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLNAH826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACLNAH826 route product structure diagram
    ACLNAH826320417-67-2
Inquiry

2. ACLNAH826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNAH826 route product structure diagram
    ACLNAH826320417-67-2
Inquiry

Comments (0)